Iorio R - Search Results

1

Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders: A Systematic Review and Meta-analysis.

Damato V, Evoli A, Iorio R. Damato V, et al. Among authors: iorio r. JAMA Neurol. 2016 Nov 1;73(11):1342-1348. doi: 10.1001/jamaneurol.2016.1637. JAMA Neurol. 2016. PMID: 27668357 Review.

2

Anorexia heralding the onset of neuromyelitis optica.

Iorio R, Plantone D, Damato V, Paola Batocchi A. Iorio R, et al. Intern Med. 2013;52(4):489-91. doi: 10.2169/internalmedicine.52.8992. Epub 2013 Feb 15. Intern Med. 2013. PMID: 23411707 Free article.

3

Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.

Iorio R, Damato V, Mirabella M, Evoli A, Marti A, Plantone D, Frisullo G, Batocchi AP. Iorio R, et al. J Neurol. 2013 Sep;260(9):2396-402. doi: 10.1007/s00415-013-6997-9. Epub 2013 Jun 21. J Neurol. 2013. PMID: 23793787

4

Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.

Iorio R, Damato V, Alboini PE, Evoli A. Iorio R, et al. J Neurol. 2015 May;262(5):1115-9. doi: 10.1007/s00415-014-7532-3. Epub 2014 Oct 12. J Neurol. 2015. PMID: 25308632 Review.

5

Rituximab in Neuromyelitis Optica Spectrum Disorders-Reply: Why Not as First-Line Therapy.

Damato V, Evoli A, Iorio R. Damato V, et al. Among authors: iorio r. JAMA Neurol. 2017 Apr 1;74(4):482-483. doi: 10.1001/jamaneurol.2016.5936. JAMA Neurol. 2017. PMID: 28166310 No abstract available.

6

Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.

Iorio R, Rindi G, Erra C, Damato V, Ferilli M, Sabatelli M. Iorio R, et al. Mult Scler. 2015 May;21(6):791-4. doi: 10.1177/1352458515572241. Epub 2015 Feb 25. Mult Scler. 2015. PMID: 25716881

7

Poly-autoimmunity in patients with myasthenia gravis: A single-center experience.

Evoli A, Caliandro P, Iorio R, Alboini PE, Damato V, LaTorre G, Provenzano C, Marino M, Lauriola L, Scuderi F, Bartoccioni E. Evoli A, et al. Among authors: iorio r. Autoimmunity. 2015;48(6):412-7. doi: 10.3109/08916934.2015.1031890. Epub 2015 Apr 14. Autoimmunity. 2015. PMID: 25868386 Free article.

8

3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies.

Evoli A, Alboini PE, Damato V, Iorio R. Evoli A, et al. Among authors: iorio r. Neurology. 2016 Mar 15;86(11):1070-1. doi: 10.1212/WNL.0000000000002466. Epub 2016 Feb 12. Neurology. 2016. PMID: 26873957 No abstract available.

9

Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.

Evoli A, Alboini PE, Iorio R, Damato V, Bartoccioni E. Evoli A, et al. Among authors: iorio r. J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):761-763. doi: 10.1136/jnnp-2017-315782. Epub 2017 Jun 10. J Neurol Neurosurg Psychiatry. 2017. PMID: 28601810

10

Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.

Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, Spagni G, Sluijs JA, Hol EM. Iorio R, et al. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):138-146. doi: 10.1136/jnnp-2017-316583. Epub 2017 Sep 26. J Neurol Neurosurg Psychiatry. 2018. PMID: 28951498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,007 results

Search Page

Filters